Publicaciones en las que colabora con FERNANDO ANTONIO RODRÍGUEZ DE FONSECA (26)

2022

  1. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease

    Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272

  2. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

    Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461

2020

  1. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102

2019

  1. Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration

    Addiction Biology, Vol. 22, Núm. 3, pp. 724-741

2016

  1. Erratum: Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats (International Journal of Neuropsychopharmacology 18:6 (DOI: 10.1093/ijnp/pyu111)

    International Journal of Neuropsychopharmacology

2015

  1. Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats

    International Journal of Neuropsychopharmacology, Vol. 18, Núm. 6, pp. 1-14

2014

  1. Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results

    Drug Design, Development and Therapy, Vol. 8, pp. 263-277

2013

  1. Description of a bivalent cannabinoid ligand with hypophagic properties

    Archiv der Pharmazie, Vol. 346, Núm. 3, pp. 171-179

  2. Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 7, pp. 1708-1716

1996

  1. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats

    Behavioural Brain Research, Vol. 75, Núm. 1-2, pp. 91-98

1994

  1. Cannabinoid receptors in rat brain areas: Sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement

    Life Sciences, Vol. 54, Núm. 3, pp. 159-170

  2. Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment

    Pharmacology, Biochemistry and Behavior, Vol. 47, Núm. 1, pp. 33-40

  3. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids

    Pharmacology, Biochemistry and Behavior, Vol. 47, Núm. 1, pp. 47-58

1993

  1. Acute effects of ∆<sup>9</sup>-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle

    Neuroendocrinology, Vol. 58, Núm. 3, pp. 280-286

  2. Presence of cannabinoid binding sites in the brain from early postnatal ages

    NeuroReport, Vol. 4, Núm. 2, pp. 135-138

  3. δ9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens

    Journal of Neural Transmission, Vol. 92, Núm. 2-3, pp. 81-95

1992

  1. Acute effects of δ-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

    Pharmacology, Biochemistry and Behavior, Vol. 42, Núm. 2, pp. 269-275

  2. Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids

    Pharmacology, Biochemistry and Behavior, Vol. 41, Núm. 3, pp. 469-474

  3. Estrogenic modulation of δ9-Tetrahydrocannabinol effects on nigrostriatal dopaminergic activity in the female rat brain

    Molecular and Cellular Neuroscience, Vol. 3, Núm. 4, pp. 315-325